Understanding clinical heterogeneity in attention deficit hyperactivity disorder (ADHD) is important for improving personalized care and long-term outcomes. A study exploits the large scale and breadth of phenotyping of the iPSYCH cohort to link clinical heterogeneity to genetic heterogeneity in ADHD.
References
Demontis, D. et al. Nat. Genet. 55, 198–208 (2023).
Demontis, D. et al. Nat. Genet. 51, 63–75 (2019).
Grotzinger, A. D. et al. Nat. Genet. 54, 548–559 (2022).
LaBianca, S. et al. Nat. Genet. https://doi.org/10.1038/s41588-023-01593-7 (2023).
Mattheisen, M. et al. Nat. Genet. 54, 1470–1478 (2022).
Satterstrom, F. K. et al. Nat. Neurosci. 22, 1961–1965 (2019).
Acknowledgements
J.G. is supported by the Australian National Health and Medical Research Council (GNT2018431) and Mater Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Yap, C.X., Gratten, J. Connecting clinical and genetic heterogeneity in ADHD. Nat Genet 56, 195–196 (2024). https://doi.org/10.1038/s41588-024-01652-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-024-01652-7
- Springer Nature America, Inc.